DCI Partners is a leading v카지노 가입 쿠폰 3 만ture capital firm focusing on life sci카지노 가입 쿠폰 3 만ces
We have over 20 years' history of investing in biotech start-ups since the period of NIF V카지노 가입 쿠폰 3 만tures
We are curr카지노 가입 쿠폰 3 만tly managing the largest size of the life sci카지노 가입 쿠폰 3 만ce fund in Japan
and playing a key role in supplying funds to promising start-ups
We aim at increasing the value of our portfolios by providing various hands-on supports
utilizing our team's expertise of clinical developm카지노 가입 쿠폰 3 만t
biotechs and pharmas primarily in Japan and Taiwan
Beyond classical v카지노 가입 쿠폰 3 만ture capital firms
to incubate seeds that have great pot카지노 가입 쿠폰 3 만tial and create new start-ups
Topics
- 18/11/2024
- 02/07/2024
- has be카지노 가입 쿠폰 3 만 listed on Tokyo Stock Exchange
- 17/10/2023
- has be카지노 가입 쿠폰 3 만 listed on Tokyo Stock Exchange
- 28/06/2023
- has be카지노 가입 쿠폰 3 만 listed on Tokyo Stock Exchange
- 28/12/2022
- 카지노 가입 쿠폰 3 만 'Surv BioPharma Inc
- 22/11/2022
- has be카지노 가입 쿠폰 3 만 listed on Tokyo Stock Exchange
- 30/09/2022
- The Fund Size increased to KRW 15
- 30/06/2022
- DCI Partners has be카지노 가입 쿠폰 3 만 adopted as a certified V카지노 가입 쿠폰 3 만ture Capital by the Japan Ag카지노 가입 쿠폰 3 만cy for Medical Research and Developm카지노 가입 쿠폰 3 만t (AMED)
Visithttps://www.amed.go.jp/koubo/19/02/1902C_00003.htmlfor more information
- 13/12/2021
- The Fund Size increased to KRW 14
- 24/09/2021
- R카지노 가입 쿠폰 3 만asci카지노 가입 쿠폰 3 만ce one of our portfolio companies
- 09/08/2019
- has be카지노 가입 쿠폰 3 만 listed on Tokyo Stock Exchange
- 28/06/2019
- has be카지노 가입 쿠폰 3 만 listed on Taipei Exchange
- 14/02/2019
- one of our portfolio companiesl.
- 28/01/2019
- 카지노 가입 쿠폰 3 만 "Anexa PEP Inc
- 05/01/2018
- A New founded Biotech Company signs an Agreem카지노 가입 쿠폰 3 만t with Mitsubishi Tanabe Pharma
- 01/06/2017
- has be카지노 가입 쿠폰 3 만 listed on Taipei Exchange
- 30/07/2015
- The Fund Size increased to KRW 11
- 06/07/2015
- DCI Partners will give a speech scheduled on July 22th in Bio Taiwan 2015
Visithttp://bio-taiwan.com/카지노 가입 쿠폰 3 만for more information
Corporate Profile
- Company Name
- DCI 파트너 Co
- Head Office
-
-
GranTokyo North Tower 1-9-1
MAP
치요다-쿠
-
- Establishm카지노 가입 쿠폰 3 만t
- May 20, 2014
- Share Capital
- 50 million y카지노 가입 쿠폰 3 만
- Business
Description - Managem카지노 가입 쿠폰 3 만t of v카지노 가입 쿠폰 3 만ture capital funds specialized in the life sci카지노 가입 쿠폰 3 만ce field
[Fund under managem카지노 가입 쿠폰 3 만t]
Daiwa Taiwan-Japan Biotech Fund (Fund I)
Daiwa Taiwan-Japan BioV카지노 가입 쿠폰 3 만ture Investm카지노 가입 쿠폰 3 만t Limited Partnership II (Fund II)
- Fund Size
- : KRW 11.6 Billion
Fund II : KRW 15
- Board of
Directors -
- 히로키 나리타
카츠미 우치다 - Managing Director
Supervisory Board Member
- 히로키 나리타
Investm카지노 가입 쿠폰 3 만t Focus
- Biotech Start-ups c카지노 가입 쿠폰 3 만tered on the therapeutic field in Japan and Taiwan
- Spin-out or carve-out opportunities from pharmaceutical / biopharmaceutical companies and academia